标题
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
作者
关键词
-
出版物
NATURE
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2017-12-06
DOI
10.1038/nature25016
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
- (2017) Lindsay A. Becker et al. NATURE
- Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism
- (2016) G P Soriano et al. LEUKEMIA
- HSF1: Guardian of Proteostasis in Cancer
- (2016) Chengkai Dai et al. TRENDS IN CELL BIOLOGY
- Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis
- (2015) Daniel J. Anderson et al. CANCER CELL
- Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas
- (2015) Yi Li et al. CANCER LETTERS
- Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer
- (2015) Jennifer L. Allensworth et al. Molecular Oncology
- A Phase IIb Trial Assessing the Addition of Disulfiram to Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer
- (2015) H. Nechushtan et al. ONCOLOGIST
- High expression of valosin-containing protein predicts poor prognosis in patients with breast carcinoma
- (2015) Yan Cui et al. TUMOR BIOLOGY
- Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells in vitro and in vivo
- (2015) Peng Liu et al. Oncotarget
- Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy
- (2014) Raymond J Deshaies BMC BIOLOGY
- Copper Signaling Axis as a Target for Prostate Cancer Therapeutics
- (2014) R. Safi et al. CANCER RESEARCH
- The p97-Ufd1-Npl4 ATPase complex ensures robustness of the G2/M checkpoint by facilitating CDC25A degradation
- (2014) Anne Riemer et al. CELL CYCLE
- Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kB pathway inhibition
- (2014) Jie Zha et al. Journal of Translational Medicine
- A Cellular System that Degrades Misfolded Proteins and Protects against Neurodegeneration
- (2014) Lili Guo et al. MOLECULAR CELL
- p97-dependent retrotranslocation and proteolytic processing govern formation of active Nrf1 upon proteasome inhibition
- (2014) Senthil K Radhakrishnan et al. eLife
- Molecular Chaperone Functions in Protein Folding and Proteostasis
- (2013) Yujin E. Kim et al. Annual Review of Biochemistry
- The p97-UFD1L-NPL4 Protein Complex Mediates Cytokine-Induced I B Proteolysis
- (2013) J.-M. Li et al. MOLECULAR AND CELLULAR BIOLOGY
- Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
- (2013) Paola Magnaghi et al. Nature Chemical Biology
- Combined Inhibition of p97 and the Proteasome Causes Lethal Disruption of the Secretory Apparatus in Multiple Myeloma Cells
- (2013) Holger W. Auner et al. PLoS One
- Alcohol drinking and all cancer mortality: a meta-analysis
- (2012) M. Jin et al. ANNALS OF ONCOLOGY
- Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system
- (2012) Hemmo Meyer et al. NATURE CELL BIOLOGY
- Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties
- (2011) N C Yip et al. BRITISH JOURNAL OF CANCER
- Targeting Malignancies with Disulfiram (Antabuse): Multidrug Resistance, Angiogenesis, and Proteasome
- (2011) B. Cvek CURRENT CANCER DRUG TARGETS
- Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram)
- (2011) Boris Cvek DRUG DISCOVERY TODAY
- Quantitative Cell-based Protein Degradation Assays to Identify and Classify Drugs That Target the Ubiquitin-Proteasome System
- (2011) Tsui-Fen Chou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mining for therapeutic gold
- (2011) Francis S. Collins NATURE REVIEWS DRUG DISCOVERY
- Cell death assays for drug discovery
- (2011) Oliver Kepp et al. NATURE REVIEWS DRUG DISCOVERY
- Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways
- (2011) T.-F. Chou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Purification of proteins containing zinc finger domains using immobilized metal ion affinity chromatography
- (2011) Irena Voráčková et al. PROTEIN EXPRESSION AND PURIFICATION
- Introduction to Danish (nationwide) registers on health and social issues: Structure, access, legislation, and archiving
- (2011) Lau Caspar Thygesen et al. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
- RNF168 Binds and Amplifies Ubiquitin Conjugates on Damaged Chromosomes to Allow Accumulation of Repair Proteins
- (2009) Carsten Doil et al. CELL
- High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth
- (2009) K. Iljin et al. CLINICAL CANCER RESEARCH
- Target identification using drug affinity responsive target stability (DARTS)
- (2009) B. Lomenick et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- UBXD7 Binds Multiple Ubiquitin Ligases and Implicates p97 in HIF1α Turnover
- (2008) Gabriela Alexandru et al. CELL
- Analysis of Npl4 deletion mutants in mammalian cells unravels new Ufd1-interacting motifs and suggests a regulatory role of Npl4 in ERAD
- (2008) Agnieszka Lass et al. EXPERIMENTAL CELL RESEARCH
- Ni(II), Cu(II), and Zn(II) Diethyldithiocarbamate Complexes Show Various Activities Against the Proteasome in Breast Cancer Cells
- (2008) Boris Cvek et al. JOURNAL OF MEDICINAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search